Suchergebnisse - "Gliptin"

PubPharm (205)

1

DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson's disease

enthalten in: GeroScience | 2024

von Yu, S. | Wang, Y. | Shen, H. | +7

2

Identification of levomenthol derivatives as potential dipeptidyl peptidase-4 inhibitors : a comparative study with gliptins

enthalten in: Journal of biomolecular structure & dynamics | 2024

von Alade, A. | Ahmed, S. | Mujwar, S. | +5

3

Bidirectional relation between dipeptidyl peptidase 4 and angiotensin II type I receptor signaling

enthalten in: American journal of physiology. Cell physiology | 2024

von Martins, F. | Ribeiro-Silva, J. | Nistala, R. | +1

4

Esophageal involvement in DPP4 inhibitor-associated bullous pemphigoid

enthalten in: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG | 2024

von Brufau-Cochs, M. | Alamon-Reig, F. | Luque-Luna, M. | +4

5

Two years with GIOIA 'Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes' : A prospective, multicentre, quasi-experimental study on sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors in diabetes clinical practice

enthalten in: Diabetes, obesity & metabolism | 2024

von Longo, M. | Caruso, P. | Scappaticcio, L. | +5

6

DPP4-Inhibitor-assoziiertes bullöses Pemphigoid mit Ösophagusbeteiligung : Esophageal involvement in DPP4 inhibitor-associated bullous pemphigoid

enthalten in: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG | 2024

von Brufau-Cochs, M. | Alamon-Reig, F. | Luque-Luna, M. | +4

7

Incretin Therapy and Insulin Signaling : Therapeutic Targets for Diabetes And Associated Dementia

enthalten in: Current diabetes reviews | 2024

von Joshi, D.

8

Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients

in: Acta Dermato-Venereologica | 2024

von Dana Shalmon | Efrat Bar-Ilan | Alon Peled | +5

9

Diabetic individuals with COVID-19 exhibit reduced efficacy of gliptins in inhibiting dipeptidyl peptidase 4 (DPP4). A suggested explanation for increased COVID-19 susceptibility in patients with type 2 diabetes mellitus (T2DM)

enthalten in: Life sciences | 2024

von Mora-Rodríguez, J. | Sánchez, B. | Bort, A. | +5

10

Immunomodulatory activity of dipeptidyl peptidase-4 inhibitors in immune-related diseases

enthalten in: European journal of immunology | 2023

von Drakul, M. | Čolić, M.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]